Role of dihydroartemisinin in regulating prostaglandin E2 synthesis cascade and inflammation in endothelial cells

Endothelial function estimated by digital reactive hyperemia in patients with atherosclerotic risk factors or coronary artery disease

(2018) Jeehoon Kang et al.   HEART AND VESSELS

Heart failure with preserved vs reduced ejection fraction following cardiac rehabilitation: impact of endothelial function

(2018) Seiya Tanaka et al.   HEART AND VESSELS

Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?

(2016) Zhe Li et al.   MOLECULES

Artesunate attenuated progression of atherosclerosis lesion formation alone or combined with rosuvastatin through inhibition of pro-inflammatory cytokines and pro-inflammatory chemokines

(2016) Weiwei Jiang et al.   PHYTOMEDICINE

25-methoxyl-dammarane-3β, 12β, 20-triol and artemisinin synergistically inhibit MDA-MB-231 cell proliferation through downregulation of testes-specific protease 50 (TSP50) expression

(2016) Danfeng Wang et al.   TUMOR BIOLOGY

Artemisinin inhibits tumour necrosis factor-α-induced vascular smooth muscle cell proliferationin vitroand attenuates balloon injury-induced neointima formation in rats

(2015) Qian Cao et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Dihydroartemisinin inhibits endothelial cell proliferation through the suppression of the ERK signaling pathway

(2015) FENGYUN DONG et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Artemisinin inhibits the proliferation, migration, and inflammatory reaction induced by tumor necrosis factor-α in vascular smooth muscle cells through nuclear factor kappa B pathway

(2015) Qian Cao et al.   JOURNAL OF SURGICAL RESEARCH

Artesunate inhibits the growth and induces apoptosis of human gastric cancer cells by downregulating COX-2

(2015) Ping Zhang et al.   OncoTargets and Therapy

Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis

(2014) Fengyun Dong et al.   CANCER BIOLOGY & THERAPY

Artemisinin prevents electric remodeling following myocardial infarction possibly by upregulating the expression of connexin 43

(2014) YONGWEI GU et al.   Molecular Medicine Reports

Effects of artesunate and ursolic acid on hyperlipidemia and its complications in rabbit

(2013) Y.L. Wang et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Inhibitory effect of dihydroartemisinin against phorbol ester-induced cyclooxygenase-2 expression in macrophages

(2013) Hyung Gyun Kim et al.   FOOD AND CHEMICAL TOXICOLOGY

Artemisinin inhibits lipopolysaccharide-induced interferon-β production in RAW 264.7 cells: Implications on signal transducer and activator of transcription-1 signaling and nitric oxide production

(2012) Ki Hwan Park et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Artemisinin Attenuates Post-Infarct Myocardial Remodeling by Down-Regulating the NF-^|^kappa;B Pathway

(2012) Yongwei Gu et al.   TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE

Dihydroartemisinin induces autophagy and inhibits the growth of iron-loaded human myeloid leukemia K562 cells via ROS toxicity

(2012) Zeng Wang et al.   FEBS Open Bio

Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling

(2010) Zhaojun Xiong et al.   EUROPEAN JOURNAL OF PHARMACOLOGY